Insight

Nitin Jain: Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL

Nitin Jain/X

Jun 12, 2025, 23:01

Nitin Jain: Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL

Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib.

Looking back at my emails Marina Konopleva and I had initial discussions with Incyte for this trial at ASH 2013! First patient enrolled Oct 2015. Thanks much Hannah Goulart for helping summarize the trial.”

Title: A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia

Authors: Hannah Goulart, Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Naveen Pemmaraju, Koichi Takahashi, Farhad Ravandi, Marina Konopleva, Nitin Jain

Read the Full Article.

Nitin Jain

More posts featuring Nitin Jain.

cancer Elias Jabbour Farhad Ravandi Hannah Goulart Koichi Takahashi Marina Konopleva Naveen Pemmaraju Nicholas J. Short Nitin Jain OncoDaily Oncology Tapan M. Kadia

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?